Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. uri icon

authors

  • Salloway, Stephen
  • Ferris, Steven
  • Reichert, Marcel
  • Ketter, Nzeera
  • Nejadnik, Bijan
  • Guenzler, Volkmar
  • Miloslavsky, Maja
  • Wang, Daniel
  • Lu, Yuan
  • Lull, Julia
  • Tudor, Iulia Cristina
  • Reisa Sperling, MD
  • Liu, Enchi
  • Grundman, Michael
  • Yuen, Eric
  • Black, Ronald
  • Brashear, H Robert
  • Fox, Nick C
  • Blennow, Kaj
  • Klunk, William
  • Raskind, Murray
  • Sabbagh, Marwan
  • Honig, Lawrence S
  • Porsteinsson, Anton P

publication date

  • January 1, 2014